Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Statistics

Total Valuation

NTLA has a market cap or net worth of $954.43 million. The enterprise value is $302.90 million.

Market Cap	954.43M
Enterprise Value	302.90M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

NTLA has 103.52 million shares outstanding. The number of shares has increased by 11.35% in one year.

Current Share Class	103.52M
Shares Outstanding	103.52M
Shares Change (YoY)	+11.35%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	90.63%
Float	97.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.75
Forward PS	21.24
PB Ratio	1.08
P/TBV Ratio	1.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.24.

Current Ratio	5.77
Quick Ratio	5.50
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.00% and return on invested capital (ROIC) is -29.71%.

Return on Equity (ROE)	-54.00%
Return on Assets (ROA)	-26.80%
Return on Invested Capital (ROIC)	-29.71%
Return on Capital Employed (ROCE)	-49.46%
Revenue Per Employee	$143,615
Profits Per Employee	-$1.29M
Employee Count	403
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.81% in the last 52 weeks. The beta is 1.97, so NTLA's price volatility has been higher than the market average.

Beta (5Y)	1.97
52-Week Price Change	-66.81%
50-Day Moving Average	10.49
200-Day Moving Average	17.72
Relative Strength Index (RSI)	41.33
Average Volume (20 Days)	3,780,262

Short Selling Information

The latest short interest is 24.42 million, so 23.59% of the outstanding shares have been sold short.

Short Interest	24.42M
Short Previous Month	24.06M
Short % of Shares Out	23.59%
Short % of Float	24.94%
Short Ratio (days to cover)	7.91

Income Statement

In the last 12 months, NTLA had revenue of $57.88 million and -$519.02 million in losses. Loss per share was -$5.25.

Revenue	57.88M
Gross Profit	-408.43M
Operating Income	-534.26M
Pretax Income	-508.80M
Net Income	-519.02M
EBITDA	-523.98M
EBIT	-534.26M
Loss Per Share	-$5.25

Balance Sheet

The company has $601.52 million in cash and $210.20 million in debt, giving a net cash position of $651.53 million or $6.29 per share.

Cash & Cash Equivalents	601.52M
Total Debt	210.20M
Net Cash	651.53M
Net Cash Per Share	$6.29
Equity (Book Value)	871.96M
Book Value Per Share	8.55
Working Capital	529.01M

Cash Flow

In the last 12 months, operating cash flow was -$348.88 million and capital expenditures -$5.78 million, giving a free cash flow of -$354.66 million.

Operating Cash Flow	-348.88M
Capital Expenditures	-5.78M
Free Cash Flow	-354.66M
FCF Per Share	-$3.43

Margins

Gross Margin	n/a
Operating Margin	-923.10%
Pretax Margin	-896.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NTLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.35%
Shareholder Yield	-11.35%
Earnings Yield	-54.38%
FCF Yield	-37.16%

Analyst Forecast

The average price target for NTLA is $39.44, which is 327.77% higher than the current price. The consensus rating is "Buy".

Price Target	$39.44
Price Target Difference	327.77%
Analyst Consensus	Buy
Analyst Count	18
Revenue Growth Forecast (5Y)	104.26%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NTLA has an Altman Z-Score of 0.64 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.64
Piotroski F-Score	3